Pharsight

Drugs that contain Indomethacin

1. Tivorbex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9089471 GENUS Formulation of indomethacin
Apr, 2030

(6 years from now)

US8734847 GENUS Formulation of indomethacin
Apr, 2030

(6 years from now)

US8992982 GENUS Formulation of indomethacin
Apr, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Feb 24, 2017

Market Authorisation Date: 24 February, 2014

Treatment: Treatment of pain

Dosage: CAPSULE;ORAL

More Information on Dosage

TIVORBEX family patents

Family Patents